New cases of adult-onset Sandhoff disease with a cerebellar or lower motor neuron phenotype

Sandhoff disease is a lipid-storage disorder caused by a defect in ganglioside metabolism. It is caused by a lack of functional N-acetyl-β-d-glucosaminidase A and B due to mutations in the HEXB gene. Typical, early-onset Sandhoff disease presents before 9 months of age with progressive psychomotor retardation and early death. A late-onset form of Sandhoff disease is rare, and its symptoms are heterogeneous. As drug trials that aim to intervene in the disease mechanism are emerging, the recognition and identification of Sandhoff disease patients—particularly those with atypical phenotypes—are becoming more important. The authors describe six new late-onset Sandhoff cases demonstrating cerebellar ataxia or lower motor neuron (LMN) involvement combined with, mostly subclinical, neuropathy. Two different mutations were found: IVS 12–26 G/A and c.1514G→A. In patients with either progressive cerebellar ataxia or LMN disease in the setting of a possibly recessive disorder, Sandhoff disease should be suspected, even when the onset age is over 45 years.

[1]  M. Wendeler,et al.  Hexosaminidase assays , 2008, Glycoconjugate Journal.

[2]  C. Zaroff,et al.  Late-onset Tay-Sachs disease: Phenotypic characterization and genotypic correlations in 21 affected patients , 2005, Genetics in Medicine.

[3]  A. Rossi,et al.  GM2 gangliosidosis with hexosaminidase A and B defect: Report of a family with motor neuron disease-like phenotype , 1986, Journal of Inherited Metabolic Disease.

[4]  T. Voisin,et al.  Adult Sandhoff disease presenting with chronic diarrhoea , 1999, Journal of Inherited Metabolic Disease.

[5]  P. Pignatti,et al.  A common β hexosaminidase gene mutation in adult Sandhoff disease patients , 1995, Human Genetics.

[6]  B. Banwell,et al.  Late-onset GM2 gangliosidosis presenting as burning dysesthesias. , 2001, Pediatric neurology.

[7]  J. Crawley,et al.  A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. , 1999, The Journal of clinical investigation.

[8]  M. Uchino,et al.  Adult Sandhoff's disease: R505Q and I207V substitutions in the HEXB gene of the first Japanese case , 1998, Journal of the Neurological Sciences.

[9]  R. Salvayre,et al.  Significance of two point mutations present in each HEXB allele of patients with adult GM2 gangliosidosis (Sandhoff disease) homozygosity for the Ile207-->Val substitution is not associated with a clinical or biochemical phenotype. , 1996, Biochimica et biophysica acta.

[10]  W. Waespe,et al.  [Adult form of GM2-gangliosidosis: a man and 2 sisters with hexosaminidase-A and -B deficiency (Sandhoff disease) and literature review]. , 1996, Swiss medical weekly.

[11]  W. Waespe,et al.  Early and severe sensory loss in three adult siblings with hexosaminidase A and B deficiency (Sandhoff disease). , 1995, Journal of neurology, neurosurgery, and psychiatry.

[12]  A. Salviati,et al.  A common beta hexosaminidase gene mutation in adult Sandhoff disease patients. , 1995, Human Genetics.

[13]  R. Modigliani,et al.  Diarrhea and autonomic dysfunction in a patient with hexosaminidase B deficiency (Sandhoff disease). , 1994, Gastroenterology.

[14]  N. Gadoth,et al.  Brain imaging in late‐onset GM2 gangliosidosis , 1993, Neurology.

[15]  F. Baas,et al.  Molecular basis of an adult form of Sandhoff disease: substitution of glutamine for arginine at position 505 of the beta-chain of beta-hexosaminidase results in a labile enzyme. , 1993, Biochimica et biophysica acta.

[16]  K. Sandhoff,et al.  Ganglioside metabolism. Enzymology, Topology, and regulation. , 1993, The Journal of biological chemistry.

[17]  S. Tsuji,et al.  An unusual splicing mutation in the HEXB gene is associated with dramatically different phenotypes in patients from different racial backgrounds. , 1992, The Journal of clinical investigation.

[18]  Takurou Kobayashi,et al.  Juvenile Sandhoff disease: a Japanese patient carrying a mutation identical to that found earlier in a Canadian patient , 1990, Journal of the Neurological Sciences.

[19]  T. Nakano,et al.  Genetic cause of a juvenile form of Sandhoff disease. Abnormal splicing of beta-hexosaminidase beta chain gene transcript due to a point mutation within intron 12. , 1989, The Journal of biological chemistry.